Abnormal eye movements in three types of chorea

Tiago Attoni; Rogério Beato; Serge Pinto; Francisco Cardoso

doi:10.1590/0004-282X20160109

Arquivos de Neuro-Psiquiatria, Table of Contents

CC BY-NC-ND 4.0 · Arq Neuropsiquiatr 2016; 74(09): 761-766
DOI: 10.1590/0004-282X20160109

VIEWS AND REVIEWS

Abnormal eye movements in three types of chorea

Anormalidades dos movimentos oculares em três tipos de coreia

Authors

Tiago Attoni

¹Universidade Federal de Minas Gerais, Programa de Pós-Graduação em Neurociências, Belo Horizonte MG, Brasil;
Rogério Beato

²Universidade Federal de Minas Gerais, Departamento de Medicina Interna, Serviço de Neurologia, Belo Horizonte MG, Brasil;
Serge Pinto

³Aix-Marseille Université /CNRS, Laboratoire Parole et Langage, Aix-en-Provence, France.
Francisco Cardoso

²Universidade Federal de Minas Gerais, Departamento de Medicina Interna, Serviço de Neurologia, Belo Horizonte MG, Brasil;

Abstract

ABSTRACT

Chorea is an abnormal movement characterized by a continuous flow of random muscle contractions. This phenomenon has several causes, such as infectious and degenerative processes. Chorea results from basal ganglia dysfunction. As the control of the eye movements is related to the basal ganglia, it is expected, therefore, that is altered in diseases related to chorea. Sydenham’s chorea, Huntington’s disease and neuroacanthocytosis are described in this review as basal ganglia illnesses that can present with abnormal eye movements. Ocular changes resulting from dysfunction of the basal ganglia are apparent in saccade tasks, slow pursuit, setting a target and anti-saccade tasks. The purpose of this article is to review the main characteristics of eye motion in these three forms of chorea.

RESUMO

Coreia é um movimento anormal caracterizado pelo fluxo contínuo de contrações musculares ao acaso. Este fençmeno possui variadas causas, como processos infecciosos e degenerativos. A coreia resulta de disfunção dos núcleos da base, os quais estão envolvidos no controle da motricidade ocular. É esperado, então, que esta esteja alterada em doenças com coreia. A coreia de Sydenham, a doença de Huntington e a neuroacantocitose são apresentadas como modelos que têm por característica este distúrbio do movimento, por ocorrência de processos que acometem os núcleos da base. As alterações oculares decorrentes de disfunção dos núcleos da base se manifestam em tarefas de sacadas, perseguição lenta, fixação de um alvo e em tarefas de antissacadas. O objetivo deste artigo é revisar as principais características dos movimentos oculares nestas três formas de coreias.

chorea - eye movements - Huntington disease - neuroacanthocytosis

coreia - movimentos oculares - doença de Huntington - neuroacantocitose

Full Text

References

References
1 Cardoso F, Seppi K, Mair KJ, Wenning GK, Poewe W. Seminar on choreas. Lancet Neurol. 2006;5(7):589-602. doi:10.1016/S1474-4422(06)70494-X
2 Cardoso F. Huntington disease and other choreas. Neurol Clin. 2009;27(3):719-36. doi:10.1016/j.ncl.2009.04.001
3 Doyle F, Cardoso F, Lopes L, Mendes M, Dias F, Cruz L et al. Infusion of Sydenham’s chorea antibodies in striatum with up-regulated dopaminergic receptors: a pilot study to investigate the potential of SC antibodies to increase dopaminergic activity. Neurosci Lett. 2012;523(2):186-9. doi:10.1016/j.neulet.2012.06.073
4 Zomorrodi A, Wald ER. Sydenham’s chorea in western Pennsylvania. Pediatrics. 2006;117(4):e675-9. doi:10.1542/peds.2005-1573
5 Cardoso F, Eduardo C, Silva AP, Mota CC. Chorea in fifty consecutive patients with rheumatic fever. Mov Disord. 1997;12(5):701-3. doi:10.1002/mds.870120512
6 Ross CA, Aylward EH, Wild EJ, Langbehn DR, Long JD, Warner JH et al. Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat Rev Neurol. 2014;10(4):204-16. doi:10.1038/nrneurol.2014.24
7 Harper PS. The epidemiology of Huntington’s disease. Hum Genet. 1992;89(4):365-76. doi:10.1007/BF00194305
8 Gusella JF, MacDonald, ME, Ambrose CM, Duyao MP. Molecular genetics of Huntington’s disease. Arch Neurol. 1993;50(11):1157-63. doi:10.1001/archneur.1993.00540110037003
9 Jung HH, Danek A, Walker RH. Neuroacanthocytosis syndromes. Orphanet J Rare Dis. 2011;6(1):68. doi:10.1186/1750-1172-6-68
10 Walker RH, Danek A, Dobson-Stone C, Guerrini R, Jung HH, Lafontaine AL et al. Developments in neuroacanthocytosis: expanding the spectrum of choreatic syndromes. Mov Disord. 2006;21(11):1794-805. doi:10.1002/mds.21108
11 Church AJ, Cardoso F, Dale RC, Lees AJ, Thompson EJ, Giovannoni G. Anti-basal ganglia antibodies in acute and persistent Sydenham’s chorea. Neurology. 2002;59(2):227-31. doi:10.1212/WNL.59.2.227
12 Harper PS. A specific mutation for Huntington’s disease. J Med Genet. 1993;30(12):975-7. doi:10.1136/jmg.30.12.975
13 Pierrot-Deseilligny C, Milea D, Müri RM. Eye movement control by the cerebral cortex. Curr Opin Neurol. 2004;17(1):17-25. doi:10.1097/00019052-200402000-00005
14 Lasker AG, Zee DS. Ocular motor abnormalities in Huntington’s disease. Vision Res. 1997;37(24):3639-45. doi:10.1016/S0042-6989(96)00169-1
15 Winograd-Gurvich CT, Georgiou-Karistianis N, Evans A, Millist L, Bradshaw JL, Churchyard A et al. Hypometric primary saccades and increased variability in visually-guided saccades in Huntington’s disease. Neuropsychologia. 2003;41(12):1683-92. doi:10.1016/S0028-3932(03)00096-4
16 Ali FR, Michell AW, Barker RA, Carpenter RHS. The use of quantitative oculometry in the assessment of Huntington’s disease. Exp Brain Res. 2006;169(2):237-45. doi:10.1007/s00221-005-0143-6
17 Patel SS, Jankovic J, Hood AJ, Jeter CB, Sereno AB. Reflexive and volitional saccades: biomarkers of Huntington disease severity and progression. J Neurol Sci. 2012;313(1-2):35-41. doi:10.1016/j.jns.2011.09.035
18 Rupp J, Dzemidzic M, Blekher T, West J, Hui S, Wojcieszek J et al. Comparison of vertical and horizontal saccade measures and their relation to gray matter changes in premanifest and manifest Huntington disease. J Neurol. 2012;259(2):267-76. doi:10.1007/s00415-011-6172-0
19 Antoniades CA, Mason SL, Carpenter RHS, Barker RA. Huntington’s disease: changes in saccades and hand-tapping over 3 years. J Neurol. 2010;257(11):1890-8. doi:10.1007/s00415-010-5632-2
20 Blekher TM, Yee RD, Kirkwood SC, Hake AM, Stout JC, Weaver MR et al. Oculomotor control in asymptomatic and recently diagnosed individuals with the genetic marker for Huntington’s disease. Vision Res. 2004;44(23):2729-36. doi:10.1016/j.visres.2004.06.006
21 Munoz DP, Coe BC. Saccade, search and orient: the neural control of saccadic eye movements. Eur J Neurosci. 2001;33(11):1945-7. doi:10.1111/j.1460-9568.2011.07739.x
22 Cairney S, Maruff P, Currie J, Currie BJ. Increased anti-saccade latency is an isolated lingering abnormality in Sydenham chorea. J Neuroophthalmol. 2009;29(2):143-5. doi:10.1097/WNO.0b013e3181a58dfa
23 Derceux MJ. Choree chronique et paralysie hypertonique du regard. Rev Neurol (Paris). 1945;77:207-8.
24 Andre-Thomas M, Abely X, Ajuriaguerra J, Eullien L. Troubles de l’elevation des globes oculaires dans un cas de choree de Huntington. Rev Neurol (Paris). 1945;77:248-50.
25 Petit H, Milbled G. Anomalies of conjugate ocular movements in Huntington’s chorea: application to early detection. Adv Neurol. 1973;1:287-94
26 Becker W, Jürgens R, Kassubek J, Ecker D, Kramer B, Landwehrmeyer B. Eye-head coordination in moderately affected Huntington’s Disease patients: do head movements facilitate gaze shifts? Exp Brain Res. 2009;192(1):97-112. doi:10.1007/s00221-008-1559-6
27 Leigh RJ, Newman SA, Folstein SE, Lasker AG, Jensen BA. Abnormal ocular motor control in Huntington’s disease. Neurology. 1983;33(10):1268-75. doi:10.1212/WNL.33.10.1268
28 Starr A. A disorder of rapid eye movements in Huntington’s chorea. Brain. 1967;90(3):545-64. doi:10.1093/brain/90.3.545
29 Avanzini G, Girotti F, Caracen T, Spreafico R. Oculomotor disorders in Huntington’s chorea. J Neurol Neurosurg Psychiatr. 1979;42(7):581-9. doi:10.1136/jnnp.42.7.581
30 Oepen G, Clarenbach P, Thoden U. Disturbance of eye movements in Huntington’s chorea. Arch Psychiatr Nervenkr (1970). 1981;229(3):205-3.
31 Leigh RJ, Parhad IM, Clark AW, Buettner-Ennever JA, Folstein SE. Brainstem findings in Huntington’s disease: possible mechanisms for slow vertical saccades. J Neurol Sci. 1985;71(2-3):247-56. doi:10.1016/0022-510X(85)90063-2
32 Bollen E, Reulen JPH, Den Heyer JC, Van der Kamp W, Roos RAC, Buruma OJS. Horizontal and vertical saccadic eye movement abnormalities in Huntington’s chorea. J Neurol Sci. 1986;74(1):11-22. doi:10.1016/0022-510X(86)90187-5
33 Tian JR, Zee DS, Lasker AG, Folstein SE. Saccades in Huntington’s disease: predictive tracking and interaction between release of fixation and initiation of saccades. Neurology. 1991;41(6):875-81. doi:10.1212/WNL.41.6.875
34 Lasker AG, Zee DS, Hain TC, Folstein SE, Singer HS. Saccades in Huntington’s disease: initiation defects and distractibility. Neurology. 1987;37(3):364-70. doi:10.1212/WNL.37.3.364
35 Rubin AJ, King WM, Reinbold KA, Shoulson I. Quantitative longitudinal assessment of saccades in Huntington’s disease. J Clin Neuroophthalmol. 1993;13(1):59-66.
36 Tsai TT, Lasker A, Zee DS. Visual atention in Huntington’s disease. Neuropsychologla. 1995;33(12):1617-26. doi:10.1016/0028-3932(95)00094-1
37 Fielding J, Georgiou-Karistianis N, Bradshaw J, Millist L, Churchyard A, White O. Accelerated time-course of inhibition of return in Huntington’s disease. Behav Brain Res. 2006;166(2):211-9. doi:10.1016/j.bbr.2005.08.004
38 Ruiz GPJ, Cenjor C, Ulmer E, Hernández J, Cantarero S, Fanjul S, García de Yébenes J. [Speed of ocular saccades in Huntington disease: prospective study]. Neurologia. 2001;16(2):70-3. Spanish.
39 Aron AR, Sahakian BJ, Robbins TW. Distractibility during selection-for-action: differential deficits in Huntington’s disease and following frontal lobe damage. Neuropsychologia. 2003;41(9):1137-47. doi:10.1016/S0028-3932(03)00034-4
40 Kirkham TH, Guitton DA. A quantitative study of abnormal eye movements in Huntington’s chorea using the scleral search coil technique. Neuro-Ophthalmol. 1984;4(1):277-38. doi:10.3109/01658108409019493
41 Collewijn H, Went LN, Tamminga EP, Vegter-Van der Vlis M. Oculomotor defects in patients with Huntington’s disease and their offspring. J Neurol Sci. 1988;86(2-3):307-20. doi:10.1016/0022-510X(88)90107-4
42 Blekher T, Johnson SA, Marshall J, White K, Hui S, Weaver M et al. Saccades in presymptomatic and early stages of Huntington disease. Neurology. 2006;67(3):394-9. doi:10.1212/01.wnl.0000227890.87398.c1
43 Grabska N, Rudzińska M, Wójcik-Pędziwiatr M, Michalski M, Sławek J, Szczudlik A. Saccadic eye movements in juvenile variant of Huntington disease. Neurol Neurochir Pol. 2014;48(4):236-41. doi:10.1016/j.pjnns.2014.06.003
44 Dursun SM, Burke JG, Andrew SH, Mlynik-Szmid A, Reveley MA. The effects of antipsychotic medication on saccadic eye movement abnormalities in Huntignton’s disease. Prog Neuropsydlopharmacol Biol Psychatry. 2000;24(6):889-96. doi:10.1016/S0278-5846(00)00116-0
45 Reilly JL, Lencer R, Bishop JR, Keedy S, Sweeney JA. Pharmacological treatment effects on eye movement control. Brain Cogn. 2008;68(3):415-35. doi:10.1016/j.bandc.2008.08.026
46 Sánchez-Pernaute R, García-Segura JM, Barrio Alba A, Viaño J, Yébenes JG. Clinical correlation of striatal 1H MRS changes in Huntington’s disease. Neurology. 1999;53(4):806-12. doi:10.1212/WNL.53.4.806
47 Kirkwood SC, Siemers E, Hodes ME, Conneally PM, Christian JC, Foroud T. Subtle changes among presymptomatic carriers of the Huntington’s disease gene. J Neurol Neurosurg Psychiatry. 2000;69(6):773-9. doi:10.1136/jnnp.69.6.773
48 Ruiz PG, Fontán A, Cenjor C, Ulmer E, Tortosa EG, Pernaute RS. [Disorders in gaze saccades in Huntington disease. Clinical correlations]. Nervenarzt. 2001;72(6):437-40. German.
49 Robert MPA, Nachev PC, Hicks SL, Golding CVP, Tabrizi SJ, Kennard C. Saccadometry of conditional rules in presymptomatic Huntington’s disease. Ann N Y Acad Sci. 2009;1164(1):444-50. doi:10.1111/j.1749-6632.2008.03736.x
50 Golding CVP, Danchaivijitr C, Hodgson TL, Tabrizi SJ, Kennard C. Identification of an oculomotor biomarker of preclinical Huntington disease. Neurology. 2006;67:485-7. doi:10.1212/01.wnl.0000218215.43328.88
51 Biglan KM, Ross CA, Langbehn DR, Aylward EH, Stout JC, Queller S et al. Motor abnormalities in premanifest persons with Huntington’s. Mov Disord. 2009;24(12):1763-72. doi:10.1002/mds.22601
52 Hicks SL, Robert MP, Golding CV, Tabrizi SJ, Kennard C. Oculomotor deficits indicate the progression of Huntington’s disease. Prog Brain Res. 2008;171:555-8. doi:10.1016/S0079-6123(08)00678-X
53 Hardie RJ, Pullon HW, Harding AE, Owen JS, Pires M, Daniels GL et al. Neuroacanthocytosis: a clinical, haematological and pathological study of 19 cases. Brain. 1991;114(1):13-49. doi:
54 Gradstein L, Danek A, Grafman J, Fitzgibbon EJ. Eye movements in chorea-acanthocytosis. Invest Ophthalmol Vis Sci. 2005;46(6):1979-87. doi:10.1167/iovs.04-1309
55 Blekher T, Weaver MR, Marshall J, Hui S, Jackson JG, Stout JC, Beristain X, Wojcieszek J, Yee RD, Foroud TM. Visual scanning and cognitive performance in prediagnostic and early-stage Huntington’s disease. Movement Disorders, 2009, v. 24, n. 4, p. 533-540.